Target intelligence / Profile preview

Hepatocyte apoptosis and injury

Molecular classification
Other (cellular process; not a discrete molecule or protein)
01

Overview

Hepatocyte apoptosis and injury refer to processes by which liver parenchymal cells die or are damaged via intrinsic (mitochondrial/caspase-mediated) or extrinsic (death receptor) pathways. Apoptosis in hepatocytes can be triggered by various insults, including toxins, immune responses, and metabolic disturbances, and contributes to inflammation, fibrosis, and the progression of liver diseases such as NASH and hepatocellular carcinoma. Apoptosis and necrosis are often concentration-dependent and can coexist; excessive apoptosis drives compensatory proliferation and can promote tumorigenesis. Key molecular mediators include the caspase family, BCL-2 family proteins, death receptors (e.g., TRAIL, TNF receptors), mitochondrial permeabilization, and regulatory kinases. Therapeutic inhibitors or modulators of these pathways are under investigation for modifying liver injury outcomes.

Other names
Hepatic apoptosisLiver cell deathHepatocyte injuryHepatic cell damageHepatic necrosis
02

Mechanism of action

Caspase inhibition (blocks apoptosis); Necroptosis inhibition (e.g., necrostatin-1); Mitochondrial protection

03

Biological functions

ApoptosisCell deathInflammationFibrosisLiver injury
04

Disease associations

Cancer (hepatocellular carcinoma)Inflammation (nonalcoholic steatohepatitis, NASH; autoimmune hepatitis)Infection (viral hepatitis)Other (drug-induced liver injury, DILI; fibrosis)
05

Safety considerations

Not applicable (as this is not a druggable target or therapeutic protein; safety challenges relate to translating apoptosis inhibition into therapy, such as risk of carcinogenesis or impaired injury clearance)
06

Interacting drugs

Caspase inhibitors (e.g., Z-VAD-fmk)

3 more in the full profile.

07

Biomarkers

ALT (alanine aminotransferase)AST (aspartate aminotransferase)Cytokeratin-18 (fragmented during apoptosis)Increased serum cytokines (TNF-α, IL-6, IFN-γ)

Beyond the preview

Go deeper on Hepatocyte apoptosis and injury.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte apoptosis and injury.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call